Skip to content
healthcare.dev

Nerlynx

NDC 70437-240, neratinib, tablet, from Puma Biotechnology, Inc..

Product NDC
70437-240
Status
Listed
Labeler
Puma Biotechnology, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208051
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70437-240 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NERATINIB MALEATE ANHYDROUS40 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
70437-240-18704370240181 BOTTLE in 1 BOX (70437-240-18) / 180 TABLET in 1 BOTTLE
70437-240-26704370240261 BOTTLE in 1 BOX (70437-240-26) / 126 TABLET in 1 BOTTLE
70437-240-33704370240331 BOTTLE in 1 BOX (70437-240-33) / 133 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d1e41dcf-e82a-47c2-a0ad-6c6eef621834

Use it

Look up 70437-240 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70437-240 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70437-240. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.